AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference

January 4, 2021 GMT

LATHAM, N.Y.--(BUSINESS WIRE)--Jan 4, 2021--

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 39 th Annual J.P. Morgan Virtual Healthcare Conference at 2:50 p.m. ET on Thursday, January 14, 2021.

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

ADVERTISEMENT

About AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210104005693/en/

CONTACT: Investor Contact:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

KEYWORD: NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SURGERY MEDICAL DEVICES OTHER HEALTH HEALTH ONCOLOGY

SOURCE: AngioDynamics, Inc.

Copyright Business Wire 2021.

PUB: 01/04/2021 04:01 PM/DISC: 01/04/2021 04:01 PM

http://www.businesswire.com/news/home/20210104005693/en